Prosecution Insights
Prosecution Insights
28 pending office actions • 24 art units • 28 examiners • 0 of 28 (0%) have an AI response strategy ready • 35 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 28 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 28 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 14 (50%) |
| §112 only | 4 (14%) |
| No statute on record | 10 (36%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIM, KIHO | 1 | 85.5% | +4.2% |
| NGANGA, BONIFACE N | 1 | 64.1% | +30.1% |
| DANG, DUY M | 1 | 91.4% | +6.0% |
| KENYON, JOHN S | 1 | 80.3% | +17.4% |
| SPENCER, ANDREA LYNNE MORRIS | 1 | 25.0% | +0.0% |
| REINIER, BARBARA DIANE | 1 | 79.7% | +9.5% |
| YOON, CHANEL J | 1 | 52.1% | +38.2% |
| STEPHENS, AMELIA CAROLE | 1 | 50.0% | +100.0% |
| WEHBE, ANNE MARIE SABRINA | 1 | 57.6% | +42.1% |
| BRETZ, COREY LANE | 1 | 0.0% | +0.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18629260 | AUTOMATED NONLINEAR REGISTRATION IN MULTI-MODALITY IMAGING | DANG, DUY M | 31d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18350077 | METHODS AND FORMULATIONS FOR GENE THERAPY, AND FOR COMBINING GENE THERAPY WITH DITPA TREATMENT, OF ALLAN-HERNDON-DUDLEY SYNDROME | BRETZ, COREY LANE | 6d |
| 18288146 | UV A LIGHT EXPOSURE INCREASES MITOCHONDRIAL ANTI-VIRAL PROTEIN EXPRESSION IN TRACHEAL CELLS VIA CELL-TO-CELL COMMUNICATION AND USES THEREOF | SPENCER, ANDREA LYNNE MORRIS | 12d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18235945 | ENDOSCOPIC FLUID ASPIRATION DEVICE | YOON, CHANEL J | 60d overdue |
| 18352622 | NOVEL AND EFFICIENT METHOD FOR REPROGRAMMING IMMORTALIZED LYMPHOBLASTOID CELL LINES TO INDUCED PLURIPOTENT STEM CELLS | WEHBE, ANNE MARIE SABRINA | 16d overdue |
| 18530467 | COMPOUNDS AND METHODS TO SENSITIZE CANCER CELLS TO TYROSINE KINASE INHIBITORS | KENYON, JOHN S | 34d |
| 18546947 | ANTI-TL1A ANTIBODY COMPOSITIONS AND METHODS OF TREATMENT IN THE LUNG | STEPHENS, AMELIA CAROLE | 50d |
| 18636419 | SYSTEM AND METHOD FOR NON-INVASIVELY PROBING IN-VIVO MITOCHONDRIAL FUNCTION USING FUNCTIONAL MRI (fMRI) | NGANGA, BONIFACE N | 53d |
| Art Unit | Apps |
|---|---|
| 1631 | 3 |
| 1635 | 2 |
| 1642 | 2 |
| 2884 | 1 |
| 3797 | 1 |
| 2662 | 1 |
| 1625 | 1 |
| 2682 | 1 |
| 3791 | 1 |
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18668909 | System, Devices, and Methods for Time-Resolved Fluorescent Spectroscopy | KIM, KIHO | 2884 | Other | Non-Final OA | 46d overdue | Pending | May 20, 2024 |
| 18636419 | SYSTEM AND METHOD FOR NON-INVASIVELY PROBING IN-VIVO MITOCHONDRIAL FUNCTION USING FUNCTIONAL MRI (fMRI) | NGANGA, BONIFACE N | 3797 | §103 | Non-Final OA | 53d | Pending | Apr 16, 2024 |
| 18629260 | AUTOMATED NONLINEAR REGISTRATION IN MULTI-MODALITY IMAGING | DANG, DUY M | 2662 | §103 | Non-Final OA | 31d overdue | Pending | Apr 08, 2024 |
| 18530467 | COMPOUNDS AND METHODS TO SENSITIZE CANCER CELLS TO TYROSINE KINASE INHIBITORS | KENYON, JOHN S | 1625 | Other | Non-Final OA | 34d | Pending | Dec 06, 2023 |
| 18288146 | UV A LIGHT EXPOSURE INCREASES MITOCHONDRIAL ANTI-VIRAL PROTEIN EXPRESSION IN TRACHEAL CELLS VIA CELL-TO-CELL COMMUNICATION AND USES THEREOF | SPENCER, ANDREA LYNNE MORRIS | 1631 | §103 | Non-Final OA | 12d | Pending | Oct 24, 2023 |
| 18367154 | DEEP LEARNING-BASED ATTENUATION CORRECTION OF CARDIAC IMAGING DATA | REINIER, BARBARA DIANE | 2682 | §103 | Non-Final OA | 22d | Pending | Sep 12, 2023 |
| 18235945 | ENDOSCOPIC FLUID ASPIRATION DEVICE | YOON, CHANEL J | 3791 | §103 | Non-Final OA | 60d overdue | Pending | Aug 21, 2023 |
| 18546947 | ANTI-TL1A ANTIBODY COMPOSITIONS AND METHODS OF TREATMENT IN THE LUNG | STEPHENS, AMELIA CAROLE | 1645 | Other | Non-Final OA | 50d | Pending | Aug 17, 2023 |
| 18352622 | NOVEL AND EFFICIENT METHOD FOR REPROGRAMMING IMMORTALIZED LYMPHOBLASTOID CELL LINES TO INDUCED PLURIPOTENT STEM CELLS | WEHBE, ANNE MARIE SABRINA | 1634 | §103 | Non-Final OA | 16d overdue | Pending | Jul 14, 2023 |
| 18350077 | METHODS AND FORMULATIONS FOR GENE THERAPY, AND FOR COMBINING GENE THERAPY WITH DITPA TREATMENT, OF ALLAN-HERNDON-DUDLEY SYNDROME | BRETZ, COREY LANE | 1635 | Other | Non-Final OA | 6d | Pending | Jul 11, 2023 |
| 18326912 | METHODS AND SYSTEMS OF STRATIFYING INFLAMMATORY DISEASE PATIENTS | HUDSON, AMY ROSE | 1636 | §103 | Non-Final OA | 46d | Pending | May 31, 2023 |
| 18320653 | Methods for Detecting and Treating Irritable Bowel Syndrome | STOICA, ELLY GERALD | 1647 | Other | Non-Final OA | 43d overdue | Pending | May 19, 2023 |
| 18011589 | PATIENT TRANSFER ASSEMBLY WITH DETACHABLE SUPPORT SURFACE | LAMPRECHT, JOEL | 3798 | §103 | Non-Final OA | 87d overdue | Pending | Dec 20, 2022 |
| 17998857 | EXOSOME-DERIVED PIWI-INTERACTING RNA AND METHODS OF USE THEREOF | KIM, TAEYOON | 1631 | §112 | Final Rejection | 23d | Pending | Nov 15, 2022 |
| 17914050 | BIOMARKER PANELS FOR STRATIFICATION OF RESPONSE TO IMMUNE CHECKPOINT BLOCKADE IN CANCER | SALMON, KATHERINE D | 1682 | §112 | Final Rejection | 27d | Pending | Sep 23, 2022 |
| 17930558 | SYSTEMS AND METHODS FOR IN VIVO DUAL RECOMBINASE-MEDIATED CASSETTE EXCHANGE (dRMCE) AND DISEASE MODELS THEREOF | MOLOYE, TITILAYO | 1632 | Other | Non-Final OA | 9d | Pending | Sep 08, 2022 |
| 17796436 | METHOD OF TREATING PANCREATIC CANCER | UNDERDAHL, THANE E | 1699 | §103 | Final Rejection | 6d | Pending | Jul 29, 2022 |
| 17766704 | CORTICAL NEURAL PROGENITOR CELLS FROM IPSCS | HUMPHRIES, NICHOLAS ADAM | 1631 | §103 | Final Rejection | 27d | Pending | Apr 05, 2022 |
| 17766706 | MESH CHOPPING OF NEURAL PROGENITOR CELL AGGREGATES | ABUZEINEH, HANAN ISAM | 1633 | §103 | Non-Final OA | 73d overdue | Pending | Apr 05, 2022 |
| 17639654 | Use of Calcineurin Inhibitor Free CTLA4-IG + Anti-IL6/IL6R For Long Term Immunosuppression in Solid Organ Transplant Recipients | OUSPENSKI, ILIA I | 1644 | Other | Final Rejection | 17d overdue | Pending | Mar 02, 2022 |
| 17565834 | METHODS OF DIAGNOSIS, SELECTION, AND TREATMENT OF DISEASES AND CONDITIONS CAUSED BY OR ASSOCIATED WITH METHANOGENS | FERNANDEZ, SUSAN EMILY | 1651 | §103 | Non-Final OA | 112d overdue | Pending | Dec 30, 2021 |
| 17617878 | SYSTEMS AND METHODS FOR IN VIVO DUAL RECOMBINASE-MEDIATED CASSETTE EXCHANGE (dRMCE) AND DISEASE MODELS THEREOF | MCLEOD, AFRICA MHAIRIE | 1635 | Other | Final Rejection | 19d overdue | Pending | Dec 09, 2021 |
| 17533065 | METHODS AND COMPOSITIONS FOR TREATING CANCER AND INFECTIOUS DISEASES | SANG, HONG | 1646 | §103 | Non-Final OA | 97d overdue | Pending | Nov 22, 2021 |
| 17435159 | ANTI-CD38 AGENTS FOR DESENSITIZATION AND TREATMENT OF ANTIBODY-MEDIATED REJECTION OF ORGAN TRANSPLANTS | STONEBRAKER, ALYSSA RAE | 1642 | §103 | Non-Final OA | 31d overdue | Pending | Aug 31, 2021 |
| 17334109 | METHODS OF STRATIFYING AND TREATING A SUB-POPULATION OF INFLAMMATORY BOWEL DISEASE PATIENTS | WHALEY, PABLO S | 3619 | §112 | Non-Final OA | 20d | Pending | May 28, 2021 |
| 17292025 | USE OF CLAZAKIZUMAB TO DESENSITIZE AND IMPROVE RENAL TRANSPLANTATION IN HLA-SENSITIZED PATIENTS | SULLIVAN, DENNIS JOHN | 1642 | Other | Final Rejection | 78d overdue | Pending | May 07, 2021 |
| 17279259 | METHODS OF TREATING AND DIAGNOSING INFLAMMATORY BOWEL DISEASE | SWIFT, CANDICE LEE | 1657 | §112 | Non-Final OA | 2d overdue | Pending | Mar 24, 2021 |
| 17266488 | COMPOSITIONS AND METHODS FOR TREATING CANCER AND AUTOIMMUNE DISEASES | LADD, CAROLYN LOUISE | 1622 | Other | Final Rejection | 56d | Pending | Feb 05, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial